Additionally, Jiang et al. found that patients with HCC who exhibited high ZDHHC7 expression had poor clinical staging and prognosis, indicating that ZDHHC7 is a novel biomarker for HCC diagnosis [35]. This evidence concerns the gene ZDHHC7 and hepatocellular carcinoma.